Abstract
Huntington's disease (HD) is associated with the expansion of a CAG trinucleotide repeat in a novel gene. We have assessed 360 HD individuals from 259 unrelated families and found a highly significant correlation (r = 0.70, p = 10−7) between the age of onset and the repeat length, which accounts for approximately 50% of the variation in the age of onset. Significant associations were also found between repeat length and age of death and onset of other clinical features. Sib pair and parent–child analysis revealed that the CAG repeat demonstrates only mild instability. Affected HD siblings had significant correlations for trinucleotide expansion (r = 0.66, p < 0.001) which was not apparent for affected parent–child pairs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials
Scientific Reports Open Access 07 November 2022
-
Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset
Nature Neuroscience Open Access 04 April 2022
-
Krankheitsmodifizierende Therapieansätze bei der Huntington-Krankheit
Der Nervenarzt Open Access 11 November 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hayden, M.R. Huntington's chorea (Springer-Verlag, New York, 1981).
Harper, P.S. Huntington's disease (W.B. Saunders, London, 1991).
Gusella, J.F. et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306, 234–238 (1983).
Huntington Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington disease chromosomes. Cell 72, 971–983 (1993).
Kremer, E.J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n . Science 252, 1711–1714 (1991).
Mahadevan, M. et al. Myotonic dystrophy mutation an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253–1255 (1992).
Fu, Y-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256–1258 (1992).
Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992).
La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79 (1991).
Fu, Y.H. et al. Variation of the CCG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67, 1047–1058 (1991).
Orr, H.T. et al. Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1. Nature Genet. 4, 221–226 (1993).
Richards, R.I. & Sutherland, G.R. Dynamic mutations: A new class of mutations causing human disease. Cell 70, 709–712 (1992).
Hayden, M.R. On planting alfalfa and growing orchids: The cloning of the gene causing Huntington disease. Clin. Genet. 43, 217–222 (1993).
Mandel, J.L. Questions of expansion. Nature Genet 4, 8–9 (1993).
Redman, J.B., Fenwick, R.G. Jr., Fu, Y.H., Pizzuti, A. & Caskey, C.T. Relationship between parental trinucleotide CTG repeat length and severity of myotonic dystrophy in offspring. J. Am. med. Assoc. 269, 1960–1965 (1993).
Tsilfidis, C., MacKenzie, A.E., Mettler, G., Barcelo, J. & Korneluk, R.G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet. 1, 192–195 (1992).
Hunter, A. et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J. med. Genet. 29, 774–779 (1992).
La Spada, A.R. et al. Meiotic stability and genotype-phenotype correlation of the expanded trinucleotide repeat sequence in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2, 301–304 (1992).
Merritt, A.D., Conneally, P.M., Rahman, N.F. & Drew, A.L., Huntington's chorea. In Progress in neurogenetics (eds Barbeau, A. & Brunnett, J.R.) 645–650 (Excerpta Medica, Amsterdam, 1969).
Farrer, L.A. & Conneally, P.M. A genetic model for age of onset in Huntington disease. Am. J. hum. Genet. 37, 350–357 (1985).
Myers, R.H., Madden, J.J., Teague, J.L. & Falek, A. Factors related to onset age in Huntington's disease. Am. J. hum. Genet. 34, 481–488 (1982).
Adams, P., Falek, A. & Arnold, J. Huntington disease in Georgia: age at onset. Am. J. hum. Genet. 43, 695–704 (1988).
Hayden, M.R., Soles, J.A. & Ward, R.H. Age of onset in siblings of persons with juvenile onset Huntington disease. Clin. Genet 28, 100–105 (1985).
Stevens, D.L. The heterozygote frequency for Huntington's chorea. In Huntington's chorea, 1872–1972 (eds Barbeau A., Chase T.N. & Paulson G.W.) 191–198 (Raven Press, New York).
Kunkel, L.M. et al. Analysis of human Y chromosome specific reiterated DNA in chromosome variants. Proc. natn. Acad. Sci. U.S.A. 74, 1245–1249 (1977).
Goldberg, Y.P., Andrew, S.E., Clarke, L.A. & Hayden, M.R. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum. molec. Genet. 6, 635–636 (1993).
Draper, N. & Smith, H. Applied regression analysis 2nd edn (Wiley, New York, 1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andrew, S., Paul Goldberg, Y., Kremer, B. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4, 398–403 (1993). https://doi.org/10.1038/ng0893-398
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0893-398
This article is cited by
-
Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials
Scientific Reports (2022)
-
Krankheitsmodifizierende Therapieansätze bei der Huntington-Krankheit
Der Nervenarzt (2022)
-
A comparative study of population genetic structure reveals patterns consistent with selection at functional microsatellites in common sunflower
Molecular Genetics and Genomics (2022)
-
CRISPR-Cas9 mediated genome editing of Huntington’s disease neurospheres
Molecular Biology Reports (2022)
-
Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset
Nature Neuroscience (2022)